Clinical Trial Update: Nebulized Lidocaine and Intranasal Midazolam for NGT Insertion in Children [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating nebulized lidocaine and intranasal midazolam to ease nasogastric tube insertion in children; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Procedural Anxiety
• Procedural Pain

Drugs mentioned

• Nebulized lidocaine (lidocaine)
• intranasal Midazolam (midazolam)

Snippet

Sponsor: Hamad Medical Corporation | Conditions: Procedural Anxiety, Procedural Pain | Phase 3 | Status: UNKNOWN